Dr. Gaglio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
185 South Orange Avenue
H-538
Newark, NJ 07103Phone+1 973-972-5252Fax+1 973-972-3144
Summary
- Paul J. Gaglio, MD is the newly appointed Director of the Division of Hepatology and Transplant Hepatology and Medical Director of the Liver Transplantation Program at Rutgers, New Jersey Medical School. He is the former director of Hepatology Outreach at NY-Presbyterian Hospital, Columbia University Medical Center, and past medical director of Adult Liver Transplantation at the Montefiore Medical Center, Columbia University, and Tulane University. Dr Gaglio received his bachelor’s in Biology/Physiology from Rutgers College in New Brunswick, NJ, and his M.D. from UMDNJ-New Jersey Medical School. He completed an internship and residency at Mount Sinai Medical Center in New York City, and a digestive disease/liver transplantation fellowship at New Jersey Medical School. Dr. Gaglio has published multiple manuscripts, book chapters, and abstracts, and has participated in numerous research trials related to the therapy of hepatitis B and C, liver transplantation, and treatment of liver failure. He is a Fellow of the American College of Physicians, the American Gastroenterological Association, and the American Association for the Study of Liver Diseases. His research interests include treatment of hepatitis B and C, the natural history of hepatitis C in liver transplant recipients, and non alcoholic fatty liver disease.
Specialties: Liver transplantation, Viral Hepatitis, Liver Disease, Acute Liver Failure, Chronic Liver Disease, Portal Hypertension, Fatty Liver Disease
Education & Training
- Rutgers Health/New Jersey Medical SchoolFellowship, Gastroenterology, 1991 - 1993
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1988 - 1991
- Rutgers New Jersey Medical SchoolClass of 1988
- Rutgers CollegeBA, Biology, Minor: Italian, Sociology, 1980 - 1984
Certifications & Licensure
- NY State Medical License 1989 - 2026
- CT State Medical License 2016 - 2025
- NJ State Medical License 1989 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2011-2022
- Marquis Who's Who In America 2013-2021
- "Best Doctors® in America" 2009-2021
- Join now to see all
Clinical Trials
- Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Start of enrollment: 2010 Sep 01
- Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 50 citationsThe Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities.Harmit Kalia, Paul J. Gaglio
Clinics in Liver Disease. 2016-05-01 - 20 citationsSocial barriers to listing for adult liver transplantation: Their prevalence and association with program characteristicsAnna Flattau, Manhal Olaywi, Paul J. Gaglio, Paula Marcus, Paul Meissner
Liver Transplantation. 2011-10-01 - 87 citationsExtracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial.Julie A. Thompson, Natasha Jones, Ali Al-Khafaji, Shahid M. Malik, David J. Reich
Liver Transplantation. 2018-03-01
Journal Articles
- Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino populationZahiruddin A, Farahmand A, Gaglio P, Massoumi H, Gastroenterol Hepatol Bed Bench, 1/1/2016
- The Prevalence and Pathobiology of NAFLD in Patients of Different Races/EthnicitiesKalia H, Gaglio PJ, Clin Liver Dis, 1/1/2016
- Nonalcoholic Fatty Liver DiseaseGaglio PJ, Clin Liver Dis, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Impact of Sustained Virologic Response on Manifestations of Portal Hypertension in Decompensated Hepatitis C Virus Cirrhosis.Izzy MN, Rabbenou W, Khaleel H, Gaglio PJ, Chacko K, Am J Gastroenterol, ACG, 1/1/2016
- Successful Treatment of Hepatitis C in Renal Transplant Recipients with Directly Acting Antiviral AgentsLubetzky, M, Akalin E, Gaglio PJ, Debocarrdo, ASTN, 1/1/2015
- Patterns of Care Since the Approval of New Therapies for Hepatitis C Virus (HCV) Infection: A 2013-2014 Real-World Analysis of US Community Specialty PracticesGaglio PJ, Sapir T, Carter JD, Green L, Rusie E, Moreo K, AASLD 2015 Hepatology, 1/1/2015
- Join now to see all
Lectures
- HCV: Updates in Difficult to Treat Patients1/1/2016
- Chronic HCV Treatment Guidelines1/1/2016
- Controversies in HCV Management1/1/2016
- Join now to see all
Other
- Medical Care of the Liver Transplant Recipient.Gaglio, PJ, Brown RS, Scott Cotler, Up to Date
1/1/2010 - A comparison of Fibrosis Progression in Chronic Liver Disease, A Randomized Control Trial of Urso in Alcoholic Hepatitis.Gaglio PJ, Brown RS, Hepatitis Index and Reviews
1/1/2003 - Long-term management of adult liver transplant recipientsGaglio PJ, Cotler SJ
http://www.uptodate.com/contents/long-term-management-of-adult-liver-transplant-recipients
UpToDate, Wolters Kluwer Health - 2012-10-16 - Join now to see all
Press Mentions
- Q&A: A New Approach to Improve Liver Transplant Rates in SeptuagenariansSeptember 23rd, 2024
- DURECT Corporation Reports Second Quarter 2023 Financial Results and Business UpdateAugust 13th, 2023
Professional Memberships
- Fellow
Other Languages
- Spanish, Italian
External Links
- linkedinhttps://www.linkedin.com/in/pauljgagliomd
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: